Acceptance and the willingness to pay for human papilloma virus (HPV) vaccine: A systematic review.
메타분석
2/5 보강
OpenAlex 토픽 ·
Cervical Cancer and HPV Research
Vaccine Coverage and Hesitancy
Economic and Environmental Valuation
Human papillomavirus (HPV) is a major global health concern due to its link to cervical and other cancers.
APA
Soheila Rajaie, Sara Emamgholipour, et al. (2026). Acceptance and the willingness to pay for human papilloma virus (HPV) vaccine: A systematic review.. Human vaccines & immunotherapeutics, 22(1), 2609345. https://doi.org/10.1080/21645515.2025.2609345
MLA
Soheila Rajaie, et al.. "Acceptance and the willingness to pay for human papilloma virus (HPV) vaccine: A systematic review.." Human vaccines & immunotherapeutics, vol. 22, no. 1, 2026, pp. 2609345.
PMID
41636135 ↗
Abstract 한글 요약
Human papillomavirus (HPV) is a major global health concern due to its link to cervical and other cancers. Although HPV vaccination is highly effective, acceptance and willingness to pay (WTP) differ widely across populations. This review summarizes global evidence from 2015-2025. A systematic search of PubMed, Scopus, CENTRAL, Web of Science, and Google Scholar was conducted in 2025 following PRISMA guidelines. Studies reporting data on knowledge, acceptance, attitudes, and WTP across any population were included. Quality assessment used ISPOR checklists, and data were synthesized in Excel 2019. Thirty-five studies met inclusion criteria, with China and Nigeria contributing most. WTP ranged from 52.68% in lower-middle-income countries to 65.38% in low-income countries. Mean WTP was highest in upper-middle-income settings. Knowledge, positive attitudes, socioeconomic status, and trust increased WTP, while cost remained the primary barrier. Improving affordability, awareness, and policy support is essential to enhance global HPV.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.